Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuderer

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Thrombosis Research|February 1, 2017
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trialAlok A Khorana, Charles W Francis, Nicole M Kuderer, et al.
Cancer Investigation|March 15, 2021
Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort AnalysisMichael J Wagner, Seth M Pollack, Lee D Cranmer, et al.
American Journal of Hematology|August 6, 2019
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE scoreKristen M Sanfilippo, Suhong Luo, Tzu-Fei Wang, et al.
JAMA Oncology|October 5, 2023
Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data PackagesAshley M Hopkins, Natansh D Modi, Ahmad Y Abuhelwa, et al.
BMJ (Clinical Research Ed.)|March 20, 2024
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysisBradley D Menz, Nicole M Kuderer, Stephen Bacchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused UpdateIan Krop, Nofisat Ismaila, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORxFabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 23, 2024
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple MyelomaRahul Banerjee, Andrew J Cowan, Marivel Ortega, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline UpdateFabrice Andre, Nofisat Ismaila, Kimberly H Allison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2007
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancerGary H Lyman, Alok A Khorana, Anna Falanga, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Thrombosis Research|February 1, 2017
Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trialAlok A Khorana, Charles W Francis, Nicole M Kuderer, et al.
Cancer Investigation|March 15, 2021
Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort AnalysisMichael J Wagner, Seth M Pollack, Lee D Cranmer, et al.
American Journal of Hematology|August 6, 2019
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE scoreKristen M Sanfilippo, Suhong Luo, Tzu-Fei Wang, et al.
JAMA Oncology|October 5, 2023
Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data PackagesAshley M Hopkins, Natansh D Modi, Ahmad Y Abuhelwa, et al.
BMJ (Clinical Research Ed.)|March 20, 2024
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysisBradley D Menz, Nicole M Kuderer, Stephen Bacchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused UpdateIan Krop, Nofisat Ismaila, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORxFabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 23, 2024
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple MyelomaRahul Banerjee, Andrew J Cowan, Marivel Ortega, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline UpdateFabrice Andre, Nofisat Ismaila, Kimberly H Allison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2007
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancerGary H Lyman, Alok A Khorana, Anna Falanga, et al.
Pageof 13